Saltar al contenido
Merck

20033

ORBO 554 H2SO4 sobre gel de sílice (20/40) 150/75 mg

W,W,W separators, O.D. × L 6 mm × 75 mm, pkg of 50 ea

Sinónimos:

ORBO Activated Silica Gel Tube

Iniciar sesión para ver los precios por organización y contrato.

Seleccione un Tamaño


Acerca de este artículo

UNSPSC Code:
47131900
NACRES:
NB.21
Servicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarle
Servicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarle

material

W,W,W separators, silica gel

agency

NIOSH 2012

product line

ORBO

composition

Bed A, 150 mg , Bed B, 75 mg

packaging

pkg of 50 ea

manufacturer/tradename

ORBO 554

technique(s)

active air sampling: suitable

O.D. × L

6 mm × 75 mm

matrix

H2SO4 coated silica gel

particle size

20-40 mesh

application(s)

air monitoring
environmental
industrial hygiene

Quality Level

General description

  • ORBO 554 H2SO4 on Silica Gel (20/40) 150/75 mg solvent desorption tube is designed for gas and vapor sampling.
  • It contains two beds of the same selective adsorbent separated by glass wool or foam.
  • Dual-layer or two-bed construction of the tube allows for any sample breakthrough to be captured in the smaller back-up bed.

Legal Information

ORBO is a trademark of Sigma-Aldrich Co. LLC

pictograms

Corrosion

signalword

Warning

Hazard Classifications

Eye Irrit. 2 - Met. Corr. 1 - Skin Irrit. 2

Clase de almacenamiento

8B - Non-combustible corrosive hazardous materials

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable


Elija entre una de las versiones más recientes:

Certificados de análisis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documentos section.

Si necesita más asistencia, póngase en contacto con Atención al cliente

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Bjørn T Moe et al.
Anticancer research, 29(4), 1047-1052 (2009-05-06)
Endometrial hyperplasia is a precursor lesion of endometrial carcinoma. Clinical studies of endometrial hyperplasia have shown that levonorgestrel (LNG) is more therapeutically effective than medroxyprogesterone acetate (MPA). The present pharmacological in vitro study was performed to compare progestin effects on
K Flo et al.
Scandinavian journal of clinical and laboratory investigation, 55(8), 715-721 (1995-12-01)
Elevated extracellular cGMP levels have been observed in various clinical conditions, and the analyte has been proposed as a diagnostic marker of cardiovascular as well as malignant diseases. However, the use of extracellular cGMP as a pathophysiological marker requires detailed
A Orbo et al.
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 117(7), 972-976 (1997-03-10)
The development of female steroid hormone-related neoplasms such as gynaecologic and mammary cancers is influenced by hormones administered exogenously. Hormonal contraceptives and hormone replacement therapy both affect the risk of developing cancers in the endometrium, cervix, ovarium, and mammary glands.
[Explorative abrasion--obsolete?].
A Orbo
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 111(19), 2397-2398 (1991-08-20)
Anne Ørbo et al.
British journal of cancer, 115(6), 725-730 (2016-08-19)
The aim of the present study was to investigate whether changes in the tissue expression of human epididymis-specific protein 4 (HE4) could predict therapy resistance and relapse after progestin hormone therapy for medium- and low-risk endometrial hyperplasia. Endometrial biopsies were

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico